跳至主要内容
临床试验/NCT05501223
NCT05501223Unknown不适用

Physician-initiated Medication Review in a Type 2 Diabetes Outpatient Clinic

Bispebjerg Hospital1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2020年11月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
50
试验地点
1
主要终点
Number of medications used at baseline compared to number of medications used at follow-up. Resulting in a rate of medications used at baseline compared to follow-up i.e. no. medication at follow-up/no. at baseline.

研究概览

简要总结

Aiming to reduce polypharmacy in patients with type 2 diabetes by using physician-initiated medication reviews.

详细描述

Patients will be randomised to either standard care(annual visit at outpatient clinic) or standard care plus an intervention. The intervention is a medication consultation of 30-60 minutes that consist of a medication review and increased cross-sectoral communication. Follow-up is 6 months. Primary outcome are number of medications used, secondary outcomes are health related quality of life and persistance of medication changes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • 12 medications in the central prescription list

排除标准

  • inability to give written consent (e.g., inability to understand the intervention or language barriers);
  • active cancer or palliative treatment;
  • admitted to the hospital.

结局指标

主要结局

Number of medications used at baseline compared to number of medications used at follow-up. Resulting in a rate of medications used at baseline compared to follow-up i.e. no. medication at follow-up/no. at baseline.

时间窗: 6 months

The no. of medications used at baseline will be compared to the no. of medications used at follow-up. This will result in a rate i.e. no. at follow-up/no. at baseline which can be compared between groups resulting in a rate ratio. Medication usage is determined by number of medications listed in the central prescription list.

次要结局

  • EQ5D index score. (a Euro Quality of Life 5-dimension 5-level (EQ-5D-5L) scale). The score is retrieved by using the validated EQ5D questionnaire which translates to a corresponding EQ5D index score using country specific value sets.(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Karl Sebastian Johansson

Dr., PhD student

Bispebjerg Hospital

研究点 (1)

Loading locations...

相似试验